MA23154A1 - Sel de (s)-phenyl-2-pyridineethanamide utile pour une thepapie. - Google Patents
Sel de (s)-phenyl-2-pyridineethanamide utile pour une thepapie.Info
- Publication number
- MA23154A1 MA23154A1 MA23459A MA23459A MA23154A1 MA 23154 A1 MA23154 A1 MA 23154A1 MA 23459 A MA23459 A MA 23459A MA 23459 A MA23459 A MA 23459A MA 23154 A1 MA23154 A1 MA 23154A1
- Authority
- MA
- Morocco
- Prior art keywords
- phenyl
- useful
- thepapia
- pyridineethanamide
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/GB1993/000689 WO1993020052A1 (fr) | 1992-04-03 | 1993-04-01 | 1-phenyl-2-(2-pyridinyl)ethylamine enantiomere pour le traitement de maladies de degenerescence du systeme nerveux |
GB939320273A GB9320273D0 (en) | 1993-04-01 | 1993-10-01 | Compound useful in therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
MA23154A1 true MA23154A1 (fr) | 1994-12-31 |
Family
ID=26302299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA23459A MA23154A1 (fr) | 1993-04-01 | 1994-04-01 | Sel de (s)-phenyl-2-pyridineethanamide utile pour une thepapie. |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0691957B1 (fr) |
JP (1) | JP3023987B2 (fr) |
CN (1) | CN1047168C (fr) |
AT (1) | ATE156813T1 (fr) |
AU (1) | AU682348B2 (fr) |
CA (1) | CA2159478C (fr) |
DE (1) | DE69404974T2 (fr) |
DK (1) | DK0691957T3 (fr) |
DZ (1) | DZ1765A1 (fr) |
ES (1) | ES2105672T3 (fr) |
FI (1) | FI109018B (fr) |
GB (1) | GB9320273D0 (fr) |
GR (1) | GR3025081T3 (fr) |
IL (1) | IL109108A (fr) |
MA (1) | MA23154A1 (fr) |
NO (1) | NO304647B1 (fr) |
PH (1) | PH30950A (fr) |
SG (1) | SG48204A1 (fr) |
WO (1) | WO1994022831A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE135206T1 (de) * | 1988-08-12 | 1996-03-15 | Astra Ab | Arylalkylamine und -amide mit krampflösender und nervenschützender wirkung |
ZA942140B (en) * | 1993-04-01 | 1994-10-03 | Fisons Corp | Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy |
SE9901340D0 (sv) * | 1999-04-15 | 1999-04-15 | Astra Pharma Prod | Novel process |
SE9901338D0 (sv) * | 1999-04-15 | 1999-04-15 | Astra Pharma Prod | Novel process |
DE10301650A1 (de) * | 2003-01-17 | 2004-07-29 | Johannes-Gutenberg-Universität Mainz | Medizinisch nützliche 1-Phenyl-2-aminomethylnaphthaline, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung |
EP2391606A4 (fr) | 2008-12-24 | 2012-06-13 | Astrazeneca Ab | Composés d'éthanamine et leur application pour le traitement de la dépression |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3422191A (en) * | 1965-01-21 | 1969-01-14 | Synergistics Inc | Compositions and methods for tranquilization employing salts of n-morpholine ethanol |
WO1993020052A1 (fr) * | 1992-04-03 | 1993-10-14 | Fisons Corporation | 1-phenyl-2-(2-pyridinyl)ethylamine enantiomere pour le traitement de maladies de degenerescence du systeme nerveux |
ATE135206T1 (de) * | 1988-08-12 | 1996-03-15 | Astra Ab | Arylalkylamine und -amide mit krampflösender und nervenschützender wirkung |
JP2514855B2 (ja) * | 1990-08-08 | 1996-07-10 | キッセイ薬品工業株式会社 | 光学活性なアラニンアニリド誘導体の酸付加塩 |
-
1993
- 1993-10-01 GB GB939320273A patent/GB9320273D0/en active Pending
-
1994
- 1994-03-24 IL IL10910894A patent/IL109108A/en not_active IP Right Cessation
- 1994-03-29 WO PCT/GB1994/000651 patent/WO1994022831A1/fr active IP Right Grant
- 1994-03-29 ES ES94911232T patent/ES2105672T3/es not_active Expired - Lifetime
- 1994-03-29 AU AU63802/94A patent/AU682348B2/en not_active Expired
- 1994-03-29 DK DK94911232.0T patent/DK0691957T3/da active
- 1994-03-29 CA CA002159478A patent/CA2159478C/fr not_active Expired - Lifetime
- 1994-03-29 PH PH48016A patent/PH30950A/en unknown
- 1994-03-29 DE DE69404974T patent/DE69404974T2/de not_active Expired - Lifetime
- 1994-03-29 AT AT94911232T patent/ATE156813T1/de active
- 1994-03-29 EP EP94911232A patent/EP0691957B1/fr not_active Expired - Lifetime
- 1994-03-29 SG SG1996007883A patent/SG48204A1/en unknown
- 1994-03-29 JP JP6521814A patent/JP3023987B2/ja not_active Expired - Lifetime
- 1994-03-30 DZ DZ940029A patent/DZ1765A1/fr active
- 1994-04-01 CN CN94103739A patent/CN1047168C/zh not_active Expired - Lifetime
- 1994-04-01 MA MA23459A patent/MA23154A1/fr unknown
-
1995
- 1995-09-28 NO NO951546A patent/NO304647B1/no not_active IP Right Cessation
- 1995-09-29 FI FI954645A patent/FI109018B/fi not_active IP Right Cessation
-
1997
- 1997-10-17 GR GR970402722T patent/GR3025081T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO953846L (no) | 1995-11-21 |
GR3025081T3 (en) | 1998-01-30 |
CA2159478A1 (fr) | 1994-10-13 |
AU6380294A (en) | 1994-10-24 |
ATE156813T1 (de) | 1997-08-15 |
WO1994022831A1 (fr) | 1994-10-13 |
DE69404974T2 (de) | 1997-12-18 |
FI109018B (fi) | 2002-05-15 |
GB9320273D0 (en) | 1993-11-17 |
DK0691957T3 (da) | 1997-10-27 |
CA2159478C (fr) | 2005-01-25 |
CN1047168C (zh) | 1999-12-08 |
EP0691957A1 (fr) | 1996-01-17 |
JPH08508292A (ja) | 1996-09-03 |
EP0691957B1 (fr) | 1997-08-13 |
AU682348B2 (en) | 1997-10-02 |
CN1098095A (zh) | 1995-02-01 |
IL109108A (en) | 1999-01-26 |
SG48204A1 (en) | 1998-04-17 |
DE69404974D1 (de) | 1997-09-18 |
IL109108A0 (en) | 1994-06-24 |
FI954645A0 (fi) | 1995-09-29 |
PH30950A (en) | 1997-12-23 |
DZ1765A1 (fr) | 2002-02-17 |
NO953846D0 (no) | 1995-09-28 |
NO304647B1 (no) | 1999-01-25 |
ES2105672T3 (es) | 1997-10-16 |
FI954645A (fi) | 1995-11-29 |
JP3023987B2 (ja) | 2000-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2704743B1 (fr) | Dispositif pour réduire la sensation de douleur. | |
TR28718A (tr) | Dinamik takilan tipte cocuk bezi. | |
EP0634189A3 (fr) | Appareil générant des ondes ultrasoniques de guérison. | |
DE69428892T2 (de) | Micropartikel verwendbar als ultraschallkontrastmittel | |
MA23154A1 (fr) | Sel de (s)-phenyl-2-pyridineethanamide utile pour une thepapie. | |
MXPA94009086A (es) | Guanidinas sustituidas terapeuticas. | |
FR2707171B1 (fr) | Pellicule adhésive pour bandage et bandage adhésif utilisant cette pellicule. | |
IS4569A (is) | Bensamíð til að meðhöndla taugahrörnunarsjúkdóma | |
DE69607180D1 (de) | Verarbeitung von flüssigkeiten | |
FR2711054B1 (fr) | Ecran de douche pour baignoire et receveur de douche. | |
ITRM940140A0 (it) | Procedimento e dispositivo per la produzione di potassa. | |
FR2691359B1 (fr) | Nouvelle application therapeutique du malate de 1-citrulline. | |
FR2708191B1 (fr) | Appareil de thérapie pour le traitement au moyen d'ondes acoustiques. | |
NO953847D0 (no) | (5)-alfafenyl-2-pyridinetanaminbenzoat og dets anvendelse som legemiddel | |
ZA966254B (en) | Use of unsubstituted and substituted n-(pyrrol-1-y)pyridinamines as anticonvulsant agents. | |
FR2689764B1 (fr) | Utilisation de dérivés de peptides pour la fabrication de médicaments inhibiteurs des endopeptidases 24.15 et 24.16. | |
KR970019262U (ko) | 사용경과시간을 알리는 컴퓨터 | |
ITMI942453A0 (it) | Procedimento per il trattamento di bisolfato di sodio contenente cromo | |
KR950004439U (ko) | 액정표시 장치의 패드 | |
ITRM930021A0 (it) | Procedimento di trattamento di lastre di trachite vetusia. | |
KR950002478U (ko) | 티브이 멀티 복합 제품의 사운드 처리장치 | |
KR950001955U (ko) | 퍼스널 컴퓨터의 전면 커버 고정 장치 | |
FI941672A0 (fi) | Modulaer flerprocesskokare |